Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan
· Delayed Price · Currency is TWD 192.00
-2.00 (-1.03%)
At close: Dec 5, 2025
Lumosa Therapeutics Revenue
Lumosa Therapeutics had revenue of 11.71M TWD in the quarter ending September 30, 2025, with 83.78% growth. This brings the company's revenue in the last twelve months to 42.59M, up 12.62% year-over-year. In the year 2024, Lumosa Therapeutics had annual revenue of 39.15M, down -31.21%.
Revenue (ttm)
42.59M
Revenue Growth
+12.62%
P/S Ratio
759.50
Revenue / Employee
990.40K
Employees
43
Market Cap
32.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.15M | -17.76M | -31.21% |
| Dec 31, 2023 | 56.92M | 30.27M | 113.63% |
| Dec 31, 2022 | 26.64M | 9.28M | 53.45% |
| Dec 31, 2021 | 17.36M | -4.29M | -19.81% |
| Dec 31, 2020 | 21.65M | -150.39M | -87.42% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 34.99M |
| PharmaEssentia | 13.82B |
| Lotus Pharmaceutical | 18.66B |
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Oneness Biotech | 117.33M |
| Center Laboratories | 1.57B |
| Pegavision | 6.90B |
| Polaris Group | 70.83M |